Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 19 | 2023 | 115 | 3.970 |
Why?
|
| Catheter Ablation | 16 | 2023 | 233 | 2.470 |
Why?
|
| Defibrillators, Implantable | 6 | 2022 | 129 | 1.970 |
Why?
|
| Electrocardiography | 8 | 2020 | 478 | 1.550 |
Why?
|
| Heart Conduction System | 6 | 2021 | 108 | 1.330 |
Why?
|
| Atrial Fibrillation | 6 | 2020 | 288 | 1.070 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2023 | 187 | 1.070 |
Why?
|
| Body Surface Potential Mapping | 6 | 2021 | 22 | 1.050 |
Why?
|
| Pacemaker, Artificial | 3 | 2021 | 87 | 0.930 |
Why?
|
| Cardiac Pacing, Artificial | 4 | 2018 | 87 | 0.910 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 6 | 2020 | 39 | 0.890 |
Why?
|
| Device Removal | 2 | 2021 | 161 | 0.840 |
Why?
|
| Ventricular Premature Complexes | 2 | 2021 | 7 | 0.830 |
Why?
|
| Heart Rate | 8 | 2023 | 492 | 0.780 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 59 | 0.730 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 121 | 0.710 |
Why?
|
| Heart Failure | 5 | 2022 | 1204 | 0.710 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 45 | 0.690 |
Why?
|
| Factor Xa Inhibitors | 1 | 2019 | 22 | 0.680 |
Why?
|
| Atrial Appendage | 1 | 2019 | 26 | 0.680 |
Why?
|
| Primary Prevention | 1 | 2019 | 85 | 0.660 |
Why?
|
| Bundle of His | 4 | 2019 | 42 | 0.660 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2017 | 72 | 0.580 |
Why?
|
| Cicatrix | 4 | 2023 | 63 | 0.560 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 376 | 0.560 |
Why?
|
| Epicardial Mapping | 3 | 2021 | 10 | 0.430 |
Why?
|
| Heart Ventricles | 5 | 2020 | 760 | 0.420 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1037 | 0.420 |
Why?
|
| Cardiac Resynchronization Therapy | 3 | 2022 | 68 | 0.400 |
Why?
|
| Atrial Flutter | 3 | 2020 | 33 | 0.400 |
Why?
|
| Bundle-Branch Block | 3 | 2022 | 48 | 0.390 |
Why?
|
| Feasibility Studies | 6 | 2021 | 751 | 0.350 |
Why?
|
| Aged | 19 | 2022 | 18423 | 0.330 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2019 | 25 | 0.330 |
Why?
|
| Humans | 34 | 2023 | 86678 | 0.320 |
Why?
|
| Prospective Studies | 9 | 2023 | 4214 | 0.300 |
Why?
|
| Middle Aged | 21 | 2022 | 25040 | 0.290 |
Why?
|
| Male | 25 | 2022 | 40988 | 0.280 |
Why?
|
| Nadolol | 2 | 2020 | 4 | 0.220 |
Why?
|
| Flecainide | 2 | 2020 | 7 | 0.220 |
Why?
|
| Female | 22 | 2022 | 44550 | 0.220 |
Why?
|
| Prosthesis Design | 2 | 2020 | 278 | 0.210 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2019 | 58 | 0.210 |
Why?
|
| Pericardium | 2 | 2019 | 65 | 0.200 |
Why?
|
| Endocardium | 2 | 2020 | 76 | 0.200 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2018 | 20 | 0.200 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2021 | 10 | 0.200 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 58 | 0.190 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 731 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 29 | 0.180 |
Why?
|
| Stroke Volume | 2 | 2019 | 456 | 0.180 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 56 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 6513 | 0.170 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 23 | 0.170 |
Why?
|
| Purkinje Fibers | 1 | 2019 | 27 | 0.170 |
Why?
|
| Heart Septum | 1 | 2019 | 45 | 0.170 |
Why?
|
| Sick Sinus Syndrome | 1 | 2018 | 9 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1673 | 0.170 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 73 | 0.170 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 3642 | 0.160 |
Why?
|
| Warfarin | 1 | 2019 | 103 | 0.160 |
Why?
|
| Atrioventricular Block | 1 | 2018 | 23 | 0.160 |
Why?
|
| Cardiology | 1 | 2019 | 123 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2019 | 329 | 0.160 |
Why?
|
| Atrioventricular Node | 1 | 2017 | 33 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 159 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 125 | 0.150 |
Why?
|
| Exons | 1 | 2019 | 450 | 0.150 |
Why?
|
| Weight Loss | 1 | 2019 | 229 | 0.150 |
Why?
|
| Treatment Outcome | 5 | 2022 | 7998 | 0.150 |
Why?
|
| Risk Factors | 4 | 2020 | 5420 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 240 | 0.150 |
Why?
|
| Fibrosis | 1 | 2017 | 203 | 0.140 |
Why?
|
| Myocardium | 1 | 2019 | 529 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 747 | 0.140 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 201 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2019 | 408 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2020 | 2264 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2017 | 241 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 592 | 0.120 |
Why?
|
| Echocardiography | 1 | 2019 | 911 | 0.120 |
Why?
|
| Hospitalization | 1 | 2018 | 851 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2023 | 8496 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 1204 | 0.100 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2010 | 3 | 0.090 |
Why?
|
| Heart Block | 2 | 2023 | 32 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2706 | 0.080 |
Why?
|
| Adult | 4 | 2021 | 25659 | 0.080 |
Why?
|
| Action Potentials | 2 | 2020 | 573 | 0.070 |
Why?
|
| Recurrence | 2 | 2018 | 1139 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 1239 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 1578 | 0.060 |
Why?
|
| Atropine | 1 | 2023 | 59 | 0.060 |
Why?
|
| Rats | 1 | 2010 | 3992 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2231 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 165 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2021 | 65 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 3680 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2023 | 711 | 0.050 |
Why?
|
| Sympathectomy | 1 | 2020 | 42 | 0.040 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2019 | 19 | 0.040 |
Why?
|
| Cardiac Catheters | 1 | 2019 | 9 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 164 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 250 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 162 | 0.040 |
Why?
|
| Patient Selection | 1 | 2022 | 686 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 244 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 5980 | 0.040 |
Why?
|
| United States | 2 | 2022 | 6681 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1686 | 0.040 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2017 | 44 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 8984 | 0.040 |
Why?
|
| Heart | 1 | 2020 | 539 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 579 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2019 | 563 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 1204 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2380 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1802 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2768 | 0.030 |
Why?
|
| Ligation | 1 | 2010 | 51 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 5214 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2010 | 57 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1221 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 973 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 26590 | 0.010 |
Why?
|